News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sanofi-Aventis (France) Q2 Net up 61 Percent
July 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Forbes -- Drugmaker Sanofi-Aventis SA said net profit rose 61 percent to euro1.7 billion ($2.2 billion) in the second quarter, thanks to lower restructuring costs, but warned that earnings may fall for the full year.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Sanofi (France)
MORE ON THIS TOPIC
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
November 14, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Pfizer Reportedly Planning To Divest BioNTech Stake
November 14, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama
November 13, 2025
·
1 min read
·
Annalee Armstrong